Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
dc.contributor.author | Macías Sánchez, Juan | |
dc.contributor.author | Neukam, Karin | |
dc.contributor.author | Mallolas Masferrer, Josep | |
dc.contributor.author | Cartón Sánchez, José Antonio | |
dc.date.accessioned | 2013-01-30T09:57:56Z | |
dc.date.available | 2013-01-30T09:57:56Z | |
dc.date.issued | 2012 | |
dc.identifier.citation | Hiv Clinical Trials, 13(2), p. 61-69 (2012); doi:10.1310/hct1302-61 | spa |
dc.identifier.issn | 1528-4336 | |
dc.identifier.uri | http://hdl.handle.net/10651/6333 | |
dc.description.statementofresponsibility | Macías, J., Neukam, K., Mallolas, J., López-Cortés, L.F., Cartón, J.A., Domingo, P., Moreno, S., Iribarren, J.A., Clotet, B., Crespo, M., De Los Santos, I., Ortega, E., Knobel, H., Jiménez-Expósito, M.J., Pineda, J.A. | |
dc.format.extent | p. 61-69 | spa |
dc.language.iso | eng | |
dc.relation.ispartof | Hiv Clinical Trials | spa |
dc.rights | © 2012 Thomas Land Publishers | |
dc.source | SCOPUS | spa |
dc.title | Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients | eng |
dc.type | journal article | |
dc.identifier.local | 20120670 | spa |
dc.identifier.doi | 10.1310/hct1302-61 | |
dc.relation.publisherversion | http://dx.doi.org/10.1310/hct1302-61 | spa |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Artículos [35714]